Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial.
Saved in:
| Title: | Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial. |
|---|---|
| Authors: | Yu, Ke‐Da1,2 (AUTHOR) yukeda@fudan.edu.cn, Wu, Si‐Yu1,2 (AUTHOR), Liu, Guang‐Yu1,2 (AUTHOR), Wu, Jiong1,2 (AUTHOR), Di, Gen‐Hong1,2 (AUTHOR), Hu, Zhen1,2 (AUTHOR), Hou, Yi‐Feng1,2 (AUTHOR), Chen, Can‐Ming1,2 (AUTHOR), Fan, Lei1,2 (AUTHOR), Tang, Li‐Chen1,2 (AUTHOR), Shen, Zhen‐Zhou1,2 (AUTHOR), Wu, Ke‐Jin3 (AUTHOR), Zhuang, Zhi‐Gang4 (AUTHOR), Zhang, Hong‐Wei5 (AUTHOR), Shao, Zhi‐Ming1,2 (AUTHOR) zhimingshao@yahoo.com, Yu, Ke-Da6,7 (AUTHOR), Wu, Si-Yu6,7 (AUTHOR), Liu, Guang-Yu6,7 (AUTHOR), Di, Gen-Hong6,7 (AUTHOR), Hou, Yi-Feng6,7 (AUTHOR) |
| Source: | Cancer (0008543X). 7/1/2019, Vol. 125 Issue 13, p2185-2193. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 0008543X |
|---|---|
| DOI: | 10.1002/cncr.32057 |
